Proteomics Intl Labs Ltd has released a press release.
Proteomics secures major pharmacokinetic testing contract
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Proteomics receives $1.2 million in R&D tax incentive
- PromarkerD distribution network expands to Britain
- PromarkerD outperforms standard of care tests for DKD
- Proteomics awarded $100,000 manufacturing funding
- September 2021 Quarterly Activities Report and Appendix 4C
Later from Proteomics International Laboratories
- December 2021 Quarterly Activities Report and Appendix 4C
- Unique panel of biomarkers identified for oesophageal cancer
- PromarkerD completes pre-assessment for Medicare rebate
- New Clinical Advisory Board for PromarkerD global rollout
- March 2022 Quarterly Activities Report and Appendix 4C
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories